We are live on
!
Find out more
William Blair & Company Portfolio holdings
AUM
$34.9B
1-Year Est. Return
18.88%
This Fund
S&P 500
This Quarter
Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
(+5.5%)
Cap. Flow
+$20.5M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$47.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$38.9M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
+$24.1M |
| 4 |
Netflix
NFLX
|
+$21.5M |
| 5 |
Waste Management
WM
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$45.3M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$33.2M |
| 3 |
Danaher
DHR
|
+$28.3M |
| 4 |
FLTX
Fleetmatics Group PLC
FLTX
|
+$25.2M |
| 5 |
Healthcare Services Group
HCSG
|
+$24.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.99% |
| 2 | Technology | 15.43% |
| 3 | Financials | 11.87% |
| 4 | Industrials | 11.27% |
| 5 | Consumer Discretionary | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
iShares US Aerospace & Defense ETF
ITA
$14.7B
| $6.08M | 0.05% |
94,290
+49,220
| +109% | +$3.18M |
|
|
PETX
277
DELISTED
Aratana Therapeutics, Inc.
PETX
| $6.08M | 0.05% |
649,531
+45,879
| +8% | +$381K |
|
|
WES
278
DELISTED
Western Gas Partners Lp
WES
| $6.07M | 0.05% |
110,235
+1,200
| +1% | +$60.1K |
|
279
Snap-on
SNA
$21.6B
| $6.07M | 0.05% |
39,911
-99
| -0.2% | -$15.3K |
|
280
Duke Energy
DUK
$96.9B
| $6.05M | 0.05% |
75,633
+6,430
| +9% | +$533K |
|
281
Nektar Therapeutics
NKTR
$2.46B
| $5.92M | 0.05% |
22,987
+1,978
| +9% | +$509K |
|
282
General Mills
GIS
$19.3B
| $5.89M | 0.05% |
92,276
-3,069
| -3% | -$214K |
|
|
WP
283
DELISTED
Worldpay, Inc.
WP
| $5.87M | 0.05% |
104,248
-17,616
| -14% | -$978K |
|
|
EGRX
284
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.79M | 0.05% |
82,655
+16,350
| +25% | +$906K |
|
285
Cogent Communications
CCOI
$666M
| $5.77M | 0.05% |
156,847
+11,562
| +8% | +$446K |
|
286
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $5.76M | 0.05% |
145,926
+26,242
| +22% | +$1.05M |
|
287
Yum! Brands
YUM
$40.3B
| $5.71M | 0.05% |
87,384
+289
| +0.3% | +$18.4K |
|
|
SHLX
288
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $5.67M | 0.05% |
176,685
-625
| -0.4% | -$19.7K |
|
289
ConocoPhillips
COP
$144B
| $5.65M | 0.05% |
129,918
-24,938
| -16% | -$1.04M |
|
290
AB InBev
BUD
$167B
| $5.62M | 0.05% |
42,755
+13,183
| +45% | +$1.67M |
|
|
RTN
291
DELISTED
Raytheon Company
RTN
| $5.6M | 0.05% |
41,149
+1,855
| +5% | +$258K |
|
292
Robert Half
RHI
$4.19B
| $5.59M | 0.05% |
147,631
-62,774
| -30% | -$2.39M |
|
293
Kohl's
KSS
$2.28B
| $5.51M | 0.05% |
125,879
-1,988
| -2% | -$83.3K |
|
294
NextEra Energy
NEE
$182B
| $5.48M | 0.05% |
179,240
-1,308
| -0.7% | -$41.2K |
|
295
PPG Industries
PPG
$26.2B
| $5.47M | 0.05% |
52,935
-575
| -1% | -$60.3K |
|
296
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$22.9B
| $5.33M | 0.05% |
133,228
-11,334
| -8% | -$457K |
|
|
DST
297
DELISTED
DST Systems Inc.
DST
| $5.29M | 0.05% |
89,800
| – | – |
|
|
GRUB
298
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $5.29M | 0.05% |
61,535
-353
| -0.6% | -$26.5K |
|
299
MGM Resorts International
MGM
$11.7B
| $5.24M | 0.05% |
201,325
+40,700
| +25% | +$988K |
|
300
T. Rowe Price
TROW
$24.7B
| $5.22M | 0.05% |
78,440
-10,990
| -12% | -$766K |
|
Similar funds
SAM
VIA
William Blair & Company's Q3 2016 Portfolio in Review
As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
- William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
- William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
- William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
- William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
- William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
- William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.
Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.